Cholesterol Embolism

Subscribe to Selected New Research on Cholesterol Embolism

110 relevant articles (5 outcomes, 4 trials/studies) found for this Disease

Description: Blocking of a blood vessel by CHOLESTEROL-rich atheromatous deposits, generally occurring in the flow from a large artery to small arterial branches. It is also called arterial-arterial embolization or atheroembolism which may be spontaneous or iatrogenic. Patients with spontaneous atheroembolism often have painful, cyanotic digits of acute onset.

Also Known As:

Embolism, Cholesterol; Atheroembolisms; Cholesterol Embolisms; Embolisms, Cholesterol; Atheroembolism

Relationship Network

Disease Context: Research Results

Cardiovascular Diseases: 18449

Vascular Diseases: 7172

Embolism and Thrombosis: 58

Embolism: 3174

Fat Embolism: 417

Cholesterol Embolism: 110

Blue Toe Syndrome: 32

Related Diseases

1.	Thrombosis (Thrombus)
2.	Hematoma
3.	Lacerations
4.	Rupture
5.	Kidney Failure (Renal Failure)
47 Diseases and 46 more articles analyzed in the Research Interface, order at left...

Experts

1.	Boero, R: 2 articles (09/2000 - 03/2000)
2.	Rollino, C: 2 articles (09/2000 - 03/2000)
3.	Pignataro, A: 2 articles (09/2000 - 03/2000)
4.	Quarello, F: 2 articles (09/2000 - 03/2000)
5.	Caramelo, Carlos: 1 article (02/2008)
6.	Urbano, José: 1 article (02/2008)
7.	Manzarbetia, Felix: 1 article (02/2008)
8.	Ohta, Miki: 1 article (05/2006)
9.	Matsumoto, Akihiro: 1 article (05/2006)
10.	Fujita, Toshiro: 1 article (05/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Cholesterol Embolism:

1.	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 07/01/2006 - "Strategies to limit the occurrence of atheroembolism, such as the use of distal embolic protection (DEP) systems, may result in improved outcomes after RA-PTAS" 07/01/2007 - "To further characterize procedure-associated atheroembolism, we analyzed recovered atheroembolic debris and clinical data from patients undergoing RA-PTAS with distal embolic protection (DEP)" 07/01/2006 - "These data suggest that DEP use may prevent renal function harm during RA-PTAS as a result of atheroembolism and warrant further investigation." Get all the results and reference details, order at left...
2.	Lipoproteins (Lipoprotein)IBA 08/01/2003 - "Low density lipoprotein (LDL) apheresis has been reported to be beneficial for cholesterol embolism-induced damage to the skin and brain." Get all the results and reference details, order at left...
3.	CholesterolIBA 02/01/2005 - "These results suggest that in acute lesions of renal cholesterol embolism, macrophages and T cells accumulate around cholesterol crystals and cause tubulointerstitial inflammatory lesions with other inflammatory cells" 12/01/2003 - "Intravascular cholesterol clefts as an incidental finding: cholesterol embolism or not?" 07/01/2003 - "Cholesterol crystal embolization to the digestive system: characterization of a common, yet overlooked presentation of atheroembolism." 02/01/2003 - "The suspected diagnosis of cholesterol embolism was confirmed by histopathological demonstration of cholesterol crystals in the wall of a small artery" 09/01/2000 - "The time interval between the procedure at risk and the onset of symptoms or signs of cholesterol atheroembolism ranged between few hours to 60 days" Get all the results and reference details, order at left...
4.	Retinaldehyde (Retinal)IBA 05/16/1998 - "On the value of research on retinal cholesterol embolism]" 02/15/1995 - "OBJECTIVE: To determine whether asymptomatic retinal cholesterol embolism is a risk factor for vascular events" 02/15/1995 - "CONCLUSION: Asymptomatic retinal cholesterol embolism is an important risk factor for cerebral infarction independent of commonly recognized vascular risk factors." 05/01/1999 - "The other principal clinical features in these patients were cardiac failure with pulmonary edema (61%), gastrointestinal ischemia (33%), cutaneous ischemia (90%), and retinal cholesterol embolism (22%)" 07/01/1981 - "However, renal cholesterol embolism may be clinically diagnosed when renal failure develops after known inciting factors or together with systemic manifestations of atheromatous embolization such as lower extremity livedo reticularis, focal digital ischemia or retinal embolism" Get all the results and reference details, order at left...
5.	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/01/2006 - "ANCA in atheroembolism; just a coincidence or bearing cause and effect?" 10/01/2002 - "A few cases of renal atheroembolism associated with antineutrophil cytoplasmic antibodies (ANCA) have been described" 02/01/2002 - "We describe a 47-year-old man who successively presented atheromatous coronary artery disease, cholesterol embolism after angioplasty, periaortitis with presence of c-ANCA, and finally typical pulmonary lesions caused by Wegener's granulomatosis" 07/01/2001 - "A case of cholesterol embolism with ANCA treated with corticosteroid and cyclophosphamide." Get all the results and reference details, order at left...
6.	Streptokinase FDA Link 02/06/1988 - "Cholesterol embolism in a renal graft after treatment with streptokinase." 05/01/1998 - "Cholesterol embolism and acute interstitial nephritis: two adverse effects of streptokinase thrombolytic therapy in the same patient." 01/01/1991 - "Syndrome of multiple cholesterol embolism after parenteral streptokinase therapy of acute myocardial infarct: description of an autopsy case]" 01/01/1991 - "Syndrome caused by multiple cholesterol embolism can be seen as a complication in patients affected by acute myocardial infarction, treated with streptokinase thrombolytic therapy" Get all the results and reference details, order at left...
7.	Heparin (Liquaemin)FDA LinkGeneric 03/01/2000 - "The appearance of cholesterol embolism could have been precipitated, in this case, by anticoagulation treatment with heparin and intense antiaggregation." 11/01/1993 - "A cholesterol embolism during heparin treatment]" 09/13/1997 - "They demonstrate that there is a risk of severe cholesterol embolism in high-risk patients after administration of low-molecular-weight heparin as for non-fractionated heparin, fibrinolytics, arteriography and cardiovascular surgery" Get all the results and reference details, order at left...
8.	AnticoagulantsIBA 08/20/1994 - "Anticoagulants were stopped and we noticed no further cholesterol embolism or further decline of renal function" 06/09/2007 - "One patient had a myeloproliferative syndrome due to essential thrombocytosis, the second patient had thromboangiitis obliterans, and the third patient had a cholesterol embolism, possibly due to the use of oral anticoagulants" Get all the results and reference details, order at left...
9.	Adrenal Cortex Hormones (Corticosteroids)IBA 08/01/2003 - "Efficiency of colchicine and corticosteroids in a leg ulceration with cholesterol embolism in a woman with rheumatoid arthritis." 03/01/2000 - "Do corticosteroids improve survival in acute renal failure due to cholesterol atheroembolism?" Get all the results and reference details, order at left...
10.	Simvastatin (Zocor)FDA LinkGeneric 07/01/2001 - "Thus, simvastatin can exert a beneficial therapeutic effect on renal cholesterol embolism." 07/01/2001 - "Potential therapeutic effect of simvastatin on progressive renal failure and nephrotic-range proteinuria caused by renal cholesterol embolism." Get all the results and reference details, order at left...
28 Drugs and Important Bio-Agents and 64 more articles analyzed in the Research Interface, order at left...

Therapies and Procedures

1.	Percutaneous Coronary Transluminal Angioplasty (PTCA) 05/01/2001 - "One patient developed atheroembolism after PTCA with recurrence of symptoms, progressive multiorgan failure and death" 02/01/2001 - "Cholesterol embolism after percutaneous transluminal coronary angioplasty procedure: a case report]" 12/01/1992 - "A case of cholesterol embolism occurring after left heart catheterization and percutaneous transluminal coronary angioplasty is reported" 03/01/1989 - "This case demonstrates that cholesterol embolism can be a serious complication of percutaneous transluminal coronary angioplasty." 03/01/1989 - "An autopsy case of cholesterol embolism following percutaneous transluminal coronary angioplasty and aortography." Get all the results and reference details, order at left...
2.	Transplants (Transplant) 01/01/2006 - "Use of the Symmetry aortic connector device (ACD) for proximal anastomosis of coronary grafts may reduce ascending aortic atheroembolism" 09/01/1996 - "Intraoperative graft atheroembolism was a major reoperation hazard" 09/01/1996 - "Coronary atheroembolism from vein grafts was the major cause of morbidity and mortality associated with reoperation" 04/01/1982 - "Atheroembolism as cause of graft failure." 10/01/1981 - "Atheroembolism as cause of graft failure in femoral distal reconstruction." Get all the results and reference details, order at left...
3.	Ligation 05/01/1990 - "In 12 patients with severe cardiopulmonary disease and limited life expectancy, exclusion-ligation bypass is an effective and safe palliative procedure for severe disseminated atheroembolism." 07/01/1987 - "In the high-risk patient, axillobifemoral bypass with iliac ligation may be used to treat recurrent painful atheroembolism to the feet" 12/01/1982 - "To reduce the incidence of atheroembolism at reoperation, we advocate ligation of the vein graft at the level of the distal anastomosis as early as possible during dissection on reopening the chest." Get all the results and reference details, order at left...
4.	Blood Component Removal (Apheresis) 04/01/1999 - "LDL apheresis as intensive lipid-lowering therapy for cholesterol embolism." 08/01/2003 - "Concerning apheresis, combined therapy consisting of plasma exchange and low to intermediate-dose corticosteroid therapy has been shown to be effective in multivisceral cholesterol embolism" 05/01/2006 - "LDL apheresis for cholesterol embolism following coronary artery bypass graft surgery--a case report." 08/01/2003 - "Low density lipoprotein (LDL) apheresis has been reported to be beneficial for cholesterol embolism-induced damage to the skin and brain." Get all the results and reference details, order at left...
5.	Plasma Exchange 08/01/2003 - "Concerning apheresis, combined therapy consisting of plasma exchange and low to intermediate-dose corticosteroid therapy has been shown to be effective in multivisceral cholesterol embolism" Get all the results and reference details, order at left...
24 Therapies and Procedures and 65 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>